WallStreetZenWallStreetZen

NASDAQ: TARA
Protara Therapeutics Inc Stock Ownership - Who owns Protara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Protara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jacqueline ZummoChf Scientific Operations Off2026-01-263,724$6.67
$24.84kSell
Jesse SheffermanCEO and President2026-01-268,732$6.67
$58.24kSell
Patrick FabbioChief Financial Officer2026-01-263,261$6.67
$21.75kSell
Hannah FryVP Controller2026-01-261,457$6.67
$9.72kSell
Patrick FabbioChief Financial Officer2026-01-203,063$5.60
$17.15kSell
Hannah FryVP Controller2026-01-202,132$5.60
$11.94kSell
Jesse SheffermanCEO and President2026-01-2016,322$5.60
$91.40kSell
Jacqueline ZummoChf Scientific Operations Off2026-01-206,578$5.60
$36.84kSell
Richard S. LevyDirector2025-05-1420,000$3.19
$63.80kBuy
Richard S. LevyDirector2025-05-1420,000$3.19
$63.80kBuy

1 of 2

TARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TARA insiders and whales buy or sell their stock.

TARA Shareholders

What type of owners hold Protara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hubert Birner10.41%5,632,802$30.53MInsider
Janus Henderson Group PLC9.51%5,141,616$27.87MInstitution
Abingworth LLP7.70%4,162,389$22.56MInsider
Tvm Life Science Ventures VI Gmbh Co Kg7.11%3,846,186$20.85MInsider
John Gordon Freund6.67%3,608,812$19.56MInsider
Velan Capital Investment Management LP5.24%2,834,652$15.36MInstitution
James E. Flynn4.48%2,422,745$13.13MInsider
Blackrock Inc4.45%2,408,868$13.06MInstitution
Vanguard Group Inc4.42%2,391,903$12.96MInstitution
Integral Health Asset Management LLC4.16%2,250,000$12.20MInstitution

1 of 3

TARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TARA55.42%44.58%Net SellingNet Selling
ANL0.05%0.00%
PALI91.19%5.57%Net BuyingNet Buying
CABA79.20%4.52%Net BuyingNet Buying
CAMP59.53%40.47%Net Buying
View Top Biotech Stocks

Protara Therapeutics Stock Ownership FAQ

Who owns Protara Therapeutics?

Protara Therapeutics (NASDAQ: TARA) is owned by 73.62% institutional shareholders, 59.21% Protara Therapeutics insiders, and 0.00% retail investors. Hubert Birner is the largest individual Protara Therapeutics shareholder, owning 5.63M shares representing 10.41% of the company. Hubert Birner's Protara Therapeutics shares are currently valued at $30.70M.

If you're new to stock investing, here's how to buy Protara Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.